Not provided
Not provided
Not provided
Not provided
Not provided
Device Deficiency
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| 3M | INDUSTRY |
Not provided
Not provided
Not provided
The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.
The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations. Adverse events will be tracked through study dental examinations and subject diaries with twice daily use of the 3M Oral Rinse used in combination with toothpaste containing one of three levels (no, medium, high) of Sodium Lauryl Sulfate (SLS).
Determine the subjects' acceptance of sloughing and/or other side effects
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Comparator: No SLS Toothpaste | Experimental | 3M Oral Rinse in combination with no SLS toothpaste (A) |
|
| Comparator: Medium SLS Toothpaste | Experimental | 3M Oral Rinse in combination with medium SLS toothpaste (B) |
|
| Comparator: High SLS Toothpaste | Experimental | 3M Oral Rinse in combination with high SLS toothpaste (C) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No SLS toothpaste | Drug | Toothpaste no Sodium Lauryl Sulfate |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing) | Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator. | End of treatment (3 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores | Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas. The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue. (upper right, upper anterior, upper left, lower left, lower anterior, lower right) |
| Measure | Description | Time Frame |
|---|---|---|
| The Number of Participants Reporting Their Acceptance Levels of Side Effects | Subjects were questioned regarding how acceptable were your side effects. Using the following responses of: Completely unacceptable, somewhat unacceptable, somewhat acceptable, completely acceptable, did not experience side effects | End of Treatment (3 weeks) |
Inclusion Criteria
Able to understand and willing to sign the informed consent;
Willing to agree to maintain confidentiality of the study and study materials;
3M employee aged 18 years and older;
Willing to return to the study facility for scheduled study visits and recalls;
Agree not to use other oral hygiene products (non-study toothpaste, non-study toothbrush, mouth rinse, chewing gum);
Agree to the study instruction and schedule
Exclusion Criteria:
A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the device under investigation;
Have a dental appointment scheduled during study duration for professional cleaning;
Is pregnant, nursing, or planning to become pregnant within the study duration;
History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
History of using a prescription antimicrobial mouth rinse during the past 3 months;
Currently taking medications which may alter gingival appearance/bleeding;
Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
Participation in any other clinical study within the last 30 days;
Resides in the same household with a subject already enrolled in the study;
Known history of sensitivity to oral hygiene products;
Currently using tobacco products (cigarettes, chewing tobacco) or vaping products (ecigarettes);
History of diabetes;
Have removable partial/full dentures;
Have orthodontic appliances;
Have medical or oral conditions that may compromise the subject's safety or interfere with the conduct and outcome of the study;
Have known sloughing within the last 3 weeks;
Have dry mouth;
Have widespread caries or chronic neglect;
Have gross pathological changes of oral soft tissues;
Have advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive alveolar bone loss);
Unsuitable for enrollment in this study based on the professional opinion of the dental examiner based on the oral exam or other reasons not specified in the protocol
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Brenda C Coalwell, BA | 3M Health Care Business Group | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| 3M Health Care | Saint Paul | Minnesota | 55144 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Comparator: No SLS Toothpaste | 3M Oral Rinse in combination with no SLS toothpaste (A) No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| FG001 | Comparator: Medium SLS Toothpaste | 3M Oral Rinse in combination with medium SLS toothpaste (B) Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| FG002 | Comparator: High SLS Toothpaste | 3M Oral Rinse in combination with high SLS toothpaste (C) High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Comparator: No SLS Toothpaste | 3M Oral Rinse in combination with no SLS toothpaste (A) No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| BG001 | Comparator: Medium SLS Toothpaste |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing) | Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator. | Posted | Count of Participants | Participants | End of treatment (3 weeks) |
|
Within 3 weeks of starting treatment
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Comparator: No SLS Toothpaste | 3M Oral Rinse in combination with no SLS toothpaste (A) No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Aphthous ulcer | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
The major limitation with this study is that the sample size goal was not reached given the early termination during the washout period of a two-period crossover design.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Brenda Coalwell, Clinical Affairs Manager | 3M Health Care Business Group | 16517362456 | bccoalwell1@mmm.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jan 7, 2020 | Sep 16, 2021 | Prot_SAP_000.pdf |
Not provided
Not provided
Not provided
The study was designed as an imbalanced 2 Period Crossover Study. However, the study was terminated during the washout period and the results reported here reflect only the period 1 results.
Not provided
Not provided
Assessors did not know what toothpaste subjects used.
| Medium SLS toothpaste | Drug | Less than or equal to X ppm Sodium Lauryl Sulfate |
|
|
| High SLS toothpaste | Drug | More than or equal to X ppm Sodium Lauryl Sulfate |
|
|
| Anti-plaque | Device | Rinse prevents bacterial adherence to teeth |
|
|
| Mid-Treatment (10 days) |
| The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores. | Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas. The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue. (upper right, upper anterior, upper left, lower left, lower anterior, lower right) | End of Treatment (3 weeks) |
3M Oral Rinse in combination with medium SLS toothpaste (B) Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| BG002 | Comparator: High SLS Toothpaste | 3M Oral Rinse in combination with high SLS toothpaste (C) High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
| BG003 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Number of Participants with Oral Tissue Sloughing at Baseline | Count of Participants | Participants |
|
| OG002 | Comparator: High SLS Toothpaste | 3M Oral Rinse in combination with high SLS toothpaste (C) High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth |
|
|
|
| Secondary | The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores | Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas. The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue. (upper right, upper anterior, upper left, lower left, lower anterior, lower right) | Posted | Count of Participants | Participants | Mid-Treatment (10 days) |
|
|
|
| Secondary | The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores. | Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas. The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue. (upper right, upper anterior, upper left, lower left, lower anterior, lower right) | Posted | Count of Participants | Participants | End of Treatment (3 weeks) |
|
|
|
| Other Pre-specified | The Number of Participants Reporting Their Acceptance Levels of Side Effects | Subjects were questioned regarding how acceptable were your side effects. Using the following responses of: Completely unacceptable, somewhat unacceptable, somewhat acceptable, completely acceptable, did not experience side effects | Posted | Count of Participants | Participants | End of Treatment (3 weeks) |
|
|
|
| 0 |
| 18 |
| 0 |
| 18 |
| 15 |
| 18 |
| EG001 | Comparator: Medium SLS Toothpaste | 3M Oral Rinse in combination with medium SLS toothpaste (B) Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth | 0 | 18 | 0 | 18 | 15 | 18 |
| EG002 | Comparator: High SLS Toothpaste | 3M Oral Rinse in combination with high SLS toothpaste (C) High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate Anti-plaque: Rinse prevents bacterial adherence to teeth | 0 | 17 | 0 | 17 | 16 | 17 |
| Breath odor | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Buccal mucosal roughening | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Dry mouth | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Dysgeusia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Dyspepsia | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Glossitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Hyperaesthesia teeth | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Hypoaesthesia oral | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Mouth injury | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Oral discomfort | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Oral mucosal exfoliation | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Oral pain | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Salivary hypersecretion | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Sensitivity of teeth | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Stomatitis | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Tongue biting | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Tongue exfoliation | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Nasopharyngitis | Infections and infestations | MedDRA | Non-systematic Assessment |
|
| Ligament sprain | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment |
|
| Device failure | Product Issues | MedDRA | Non-systematic Assessment |
|
Not provided
Not provided
Not provided
| (0.5, 1.0] |
|
| (1.0, 1.5] |
|
| (1.5, 2.0] |
|
| (0.5, 1.0] |
|
| (1.0, 1.5] |
|
| Somewhat acceptable |
|
| Completely acceptable |
|
| Did not experience side effects |
|